The NAD Shot Promises Big, but Your Body Clears It Almost Immediately
NAD+ itself is genuinely important. It's central to energy production, redox balance, DNA repair, and the activity of sirtuins (enzymes involved in aging and metabolism). Levels decline with age and in conditions like heart failure and neurodegeneration. The logic of boosting it makes sense on paper. The problem is that the leap from "NAD+ matters" to "injecting it helps you" skips over most of the science.
What NAD+ Actually Does in Your Body
NAD+ isn't some exotic supplement ingredient. It's a core metabolic molecule your cells already rely on for several critical functions:
- Energy production: fueling the metabolic pathways that convert food into usable cellular energy
- DNA repair: supporting the enzymes that fix daily damage to your genetic material
- Redox balance: maintaining the chemical equilibrium cells need to function properly
- Sirtuin activity: activating proteins linked to aging, inflammation, and metabolic health
The decline of NAD+ with age is well-documented, and lower levels are associated with cardiometabolic and neurodegenerative disease. Animal studies show that raising NAD+ through precursors like NMN, NR, or niacinamide improves metabolism, mitochondrial function, and inflammation across models of obesity, fatty liver, heart failure, and neurodegeneration.
The animal data is genuinely promising. The human data is where things get thin.
IV NAD+ vs. Cheaper Alternatives: A Surprising Mismatch
One of the more striking findings from human research is that intravenous NAD+ isn't even the best way to raise your NAD+ levels. When researchers compared IV NAD+, IV NR (nicotinamide riboside), and oral NR in healthy adults, the results were not what the IV drip industry would want you to see.
| Route | What Happened | Tolerability |
|---|---|---|
| IV NAD+ (infusion) | Plasma NAD+ rapidly cleared; metabolites appeared in urine | More infusion discomfort, neutrophil rise |
| IV NR (500 mg) | Blood NAD+ rose ~21% | Well tolerated, only minor transient issues |
| Oral NR | Smaller NAD+ increase than IV NR | Well tolerated |
IV NR at 500 mg raised blood NAD+ by roughly 21% and was better tolerated than IV NAD+ itself. Meanwhile, IV NAD+ caused more discomfort during infusion and triggered a rise in neutrophils (a type of white blood cell associated with inflammation or immune activation). The oral form of NR had a smaller effect than the IV version but came with the fewest issues.
So the expensive drip may actually be less effective and less comfortable than a precursor delivered the same way, or even taken by mouth.
The One Population Where IV NAD+ Showed a Real Signal
The most clinically interesting human trial involved patients with ischemic cardiomyopathy (a form of heart failure caused by reduced blood flow). After seven days of IV NAD+, these patients showed a modest improvement in left ventricular ejection fraction (a measure of how well the heart pumps) compared to placebo, along with trends toward fewer cardiac events.
This is a meaningful signal, but it comes with major caveats. The trial was small and short-term. The researchers themselves noted it needs larger, longer trials to confirm. And critically, this involved sick patients with a specific condition, not healthy people seeking an energy boost or anti-aging benefit.
Oral NMN: Safe in the Short Term, Unproven Beyond That
For those looking at the pill form, oral NMN (nicotinamide mononucleotide) at doses up to 1,250 mg per day for four weeks produced no serious adverse events in healthy adults, with lab results staying within normal range. That's reassuring for short-term safety, but it tells us nothing about whether it actually does anything beneficial in healthy people, or what happens with months or years of use.
Where the Evidence Hits a Wall
Systematic reviews of NAD+ precursors paint a consistent picture: promising preclinical results, very few well-powered human trials, and no clarity on optimal dosing or route of administration. The research doesn't yet answer the questions most people paying for NAD shots are asking:
- Does it slow aging in humans? No rigorous human evidence supports this yet.
- Does it boost energy in healthy people? Not tested in the IV infusion study; no clinical benefit was assessed.
- Is long-term use safe? Unknown. Concerns exist about possible promotion of tumor growth or harmful metabolites in some contexts.
- What's the right dose or route? Unclear. Effects appear to depend strongly on dose, route, and whether someone has an underlying disease.
The spa-style NAD "detox" or anti-aging IV protocols that clinics offer typically exceed what has been rigorously tested and are not standard medical care.
The Cost-Benefit Calculation
Here's a practical framework based on what the research currently supports:
| If you are... | What the evidence suggests |
|---|---|
| Healthy and curious about anti-aging | No human data showing clinical benefit from NAD shots; oral NR or NMN is cheaper, safer short-term, and about as well-supported |
| Managing a specific condition (e.g., heart failure) | Early, small signals exist for IV NAD+ in heart failure, but this is experimental and not ready for routine use |
| Considering long-term supplementation | Short-term safety of oral NMN looks acceptable (up to 4 weeks tested); long-term risks including possible tumor promotion are unresolved |
| Weighing IV NAD+ vs. IV or oral precursors | IV NR outperformed IV NAD+ for raising blood levels and was better tolerated; oral NR is the simplest option with the least downside |
The underlying biology of NAD+ is real and important. The decline with age is real. The animal data is compelling. But the current state of human evidence does not justify the confidence, or the price tag, that most NAD shot providers attach to their services. If you're going to experiment, oral precursors offer a similar or better evidence base with lower cost, lower risk, and no needle.
